ob.cervical-insufficiency.v1PRODUCTION

ob.cervical-insufficiency.v1

Cervical Insufficiency (Painless 2nd-Trimester Cervical Dilation)

obstetricssubacutepregnancyadult

Hard-required inputs

0 / 16

Care setting:

Encounter flow

12/12 authored

Canonical 12-phase frame with authored status for this dossier.

Current phase

Frame

Detailed

Cervical insufficiency = painless cervical dilation in 2nd trimester (typically 16-24 wk) without contractions, with risk of mid-trimester loss or extreme-preterm birth. Pathophysiology is mechanical (cervical structural weakness) rather than the contraction-driven mechanism of PTL. Partition by indication tier: history-indicated (prior 2nd-trimester loss) vs ultrasound-indicated (prior PTB + current CL < 25 mm) vs physical-exam-indicated (dilated cervix + bulging membranes) vs asymptomatic-short-cervix-no-prior-PTB (vaginal progesterone). Distinguishes from preterm labor (regular contractions + cervical change at 20-37 wk; routes to ob.preterm-labor.v1), placental abruption (painful bleeding; ob.placental-abruption.v1), chorioamnionitis (fever + Higgins criteria; ob.chorioamnionitis.v1).

Inputs

Actions

Advance rule

Set

Advance when

GA + indication-tier classification + contractions absent (defining CI feature) confirmed

Patient inputs (20)

prior_second_trimester_loss_count_and_features*history • CONTEXT

not present

Prior 2nd-trimester loss attributable to painless dilation (rather than abruption / abnormal placentation / infection) is the substrate for history-indicated cerclage; ≥ 1 prior loss (some criteria ≥ 2) drives elective cerclage at 12-14 wk

prior_spontaneous_preterm_birth_count_and_GA*history • CONTEXT

Prior spontaneous preterm birth + current short cervix < 25 mm singleton drives US-indicated cerclage decision per Berghella 2011 + Owen 2009

multifetal_gestation_status*history • CONTEXT

Twin / triplet — routine cerclage NOT recommended (Berghella 2017 IPD meta-analysis); rescue cerclage at advanced dilation per Roman 2020 reduces sPTB subgroup; vaginal progesterone NOT effective for multifetal (Romero 2018 PMID 29630885)

maternal_hr*vital • CONTEXT

Maternal tachycardia + fever supports chorio; sepsis screen if disproportionate

maternal_bp*vital • CONTEXT

BP screens for pre-eclampsia overlay (rare in CI population given GA but indicated-preterm-birth ddx); informs anesthesia planning for cerclage

gestational_age_weeks*demographic • FRAME

GA partitions decision branches: pre-conception (counseling); 12-14 wk (elective history-indicated cerclage); 16-23+6 wk (US- or exam-indicated cerclage); ≥ 24 wk (cerclage too late typically); 36-37 wk (elective removal)

contractions_status*symptom • FRAME

CI is by definition PAINLESS dilation; presence of regular contractions reclassifies as PTL and routes to ob.preterm-labor.v1

transvaginal_cervical_length_ultrasound*imaging • INITIAL_WORKUP

not present

TVUS CL is the gold-standard cervical assessment; thresholds: < 25 mm at 16-23 wk + prior PTB → US-indicated cerclage (Berghella 2011); < 25 mm at 18-24 wk no prior PTB → vaginal progesterone (Hassan 2011); serial surveillance q1-2 wk in high-risk

speculum_examination_cervical_visualization*imaging • INITIAL_WORKUP

not present

Sterile speculum to visualize cervical dilation and amniotic membranes — bulging membranes through dilated os at 16-24 wk without contractions is physical-exam-indicated rescue cerclage substrate (CIPRACT 2003)

obstetric_ultrasound_growth_and_anatomy*imaging • INITIAL_WORKUP

not present

Confirm GA + viability + anatomy + amniotic fluid volume + placenta location (abruption ddx); guide cerclage decision

maternal_cbc_with_diff*lab • INITIAL_WORKUP

WBC > 15K without antenatal steroids supports chorio (Higgins 2016) — chorio is cerclage contraindication; baseline pre-procedural

maternal_urine_culture_and_ua*lab • INITIAL_WORKUP

Asymptomatic bacteriuria / UTI is a PTB risk factor — treat to reduce preterm birth and pre-procedural infection risk before cerclage (ACOG PB 130)

cervicovaginal_swab_gbs_chlamydia_gonorrhea_bv*lab • INITIAL_WORKUP

STI / BV screen — pre-procedural cerclage workup; treat positive infections before cerclage placement

maternal_temperature*vital • RED_FLAGS

Fever screens for chorio (Higgins 2016) — chorio is a contraindication to rescue cerclage and mandates removal of cerclage in situ

vaginal_bleeding_amount_and_pattern*symptom • RED_FLAGS

Vaginal bleeding excludes pure CI diagnosis — abruption ddx routes to ob.placental-abruption.v1; light bloody show acceptable at advanced cervical dilation

rupture_of_membranes_status*symptom • RED_FLAGS

PPROM (ROM at < 37 wk) after cerclage placement — case-by-case removal decision usually within 24-48 h given ascending infection risk; routes to ob.preterm-labor.v1 (PPROM branch)

cervical_procedure_historyhistory • CONTEXT

not present

LEEP / cone biopsy / D&C with cervical injury — iatrogenic CI risk factor; informs cerclage decision threshold (ACOG PB 234)

uterine_anomaly_or_connective_tissue_historyhistory • CONTEXT

not present

Congenital uterine anomaly (Mullerian fusion defect; bicornuate / septate uterus) or connective tissue disorder (Ehlers-Danlos) — structural CI risk factor; mandates workup post-loss for next-pregnancy planning

prior_cerclage_history_and_outcomehistory • CONTEXT

not present

Prior transvaginal cerclage failure → transabdominal cerclage consideration in next pregnancy (laparoscopic or laparotomy); mandates cesarean delivery and left in situ for future pregnancies

maternal_coagulation_panellab • INITIAL_WORKUP

Pre-procedural workup for cerclage anesthesia (regional preferred)

* = hard-required. Engine cannot meaningfully run until these are filled.

Severity triggers (10)

10 need judgement

informationalsevereultrasound_indicated_cerclage_short_cervix
Prior spontaneous preterm birth + current singleton pregnancy + TVUS cervical length < 25 mm before 24 wk → cerclage placement between 16+0 and 23+6 wk (Berghella Obstet Gynecol 2011 PMID 21446209; Owen Am J Obstet Gynecol 2009 PMID 19788970). Reduces preterm birth before 35 wk (RR 0.70), previable birth, and perinatal mortality + composite morbidity. Pre-procedural infection screen + treat. Post-procedural observation 24-48 h. Serial TVUS surveillance q1-2 wk.
Trigger could not be auto-evaluated — needs clinician judgement.
informationalsevererescue_cerclage_dilated_cervix_with_bulging_membranes
Cervical dilation ≥ 1-2 cm + visible / bulging amniotic membranes 16+0 to 23+6 wk WITHOUT contractions, infection, or bleeding → emergent rescue cerclage with pre-procedural antibiotics + indomethacin tocolysis (if < 32 wk) per CIPRACT Althuisius 2003 PMID 14586323 + ACOG PB 234. Efficacy controversial; observational + case-series data suggest GA prolongation 4-6 wk. Informed consent essential.
Trigger could not be auto-evaluated — needs clinician judgement.
informationalseverecerclage_complication_with_ptl_or_chorio_or_pprom
Cerclage in situ + complication emergence: (a) regular contractions / PTL refractory to tocolysis → emergent cerclage REMOVAL to avoid cervical laceration; (b) maternal fever + Higgins 2016 criteria → CHORIO → MANDATORY cerclage removal + ampicillin + gentamicin empirics + expedite delivery; (c) PPROM at < 37 wk → case-by-case removal usually within 24-48 h given ascending infection risk; (d) significant vaginal bleeding → case-by-case observation vs removal depending on abruption ddx. Routes to ob.preterm-labor.v1 or ob.chorioamnionitis.v1 or ob.placental-abruption.v1 with cerclage carryover state.
Trigger could not be auto-evaluated — needs clinician judgement.
informationalsevererecurrent_loss_despite_cerclage
Recurrent 2nd-trimester loss after prior transvaginal cerclage → workup uterine anomaly (3D US / saline-infusion sonohysterogram) + connective-tissue (Ehlers-Danlos) + autoimmune; consider transabdominal cerclage (laparoscopic or laparotomy) pre-conception or first-trimester placement in next pregnancy. Transabdominal cerclage mandates cesarean delivery and is left in situ for future pregnancies.
Trigger could not be auto-evaluated — needs clinician judgement.
informationalseverepprom_after_cerclage_decision
PPROM at < 37 wk in patient with cerclage in situ → case-by-case decision regarding cerclage removal — usually within 24-48 h of PPROM diagnosis given high ascending infection risk (cerclage = foreign body). Concurrent corticosteroids (24+0 - 33+6 wk + delivery anticipated < 7 d) + latency antibiotics (ampicillin 2 g IV q6h × 48 h then amoxicillin 250 mg PO q8h × 5 d + erythromycin 250 mg IV q6h × 48 h then 333 mg PO q8h × 5 d per NICHD-MFMU 1997) + magnesium neuroprotection if < 32 wk per ob.preterm-labor.v1 PPROM branch. Close chorio surveillance.
Trigger could not be auto-evaluated — needs clinician judgement.
informationalmoderatevaginal_progesterone_short_cervix_no_prior_ptb
Asymptomatic singleton + TVUS cervical length < 25 mm (preferred < 20 mm) at 18-24 wk WITHOUT prior preterm birth → vaginal progesterone 200 mg PV nightly through 36+6 wk (Hassan Ultrasound Obstet Gynecol 2011 PMID 21472815 + Romero AJOG 2018 PMID 29630885). NOT cerclage indication per Berghella 2017 IPD meta-analysis (cerclage not beneficial in this subgroup; use vaginal progesterone instead). NOT effective in multifetal gestations.
Trigger could not be auto-evaluated — needs clinician judgement.
informationalmoderatetwin_pregnancy_with_short_cervix
Twin pregnancy + asymptomatic cervical dilation ≥ 1 cm at 16+0 to 23+6 wk WITHOUT contractions / infection / bleeding → rescue cerclage per Roman Am J Obstet Gynecol 2020 PMID 32592693 (RR 0.71 for sPTB < 34 wk; subgroup analysis). Routine cerclage in twins still NOT recommended per ACOG PB 234 + Berghella Cochrane 2017. Vaginal progesterone NOT effective for multifetal per Romero 2018 PMID 29630885. Informed consent re subgroup benefit + procedure risk.
Trigger could not be auto-evaluated — needs clinician judgement.
informationalmoderatepreconception_counseling_with_history
Pre-conception or first-trimester counseling for patient with prior cervical insufficiency-attributable mid-trimester loss → MFM consultation; cerclage planning for next pregnancy (history-indicated elective at 12-14 wk vs US-indicated 16-23+6 wk depending on TVUS surveillance); uterine-anomaly workup (3D US / saline-infusion sonohysterogram); connective-tissue / autoimmune review; recurrence-risk counseling (~ 30 % without cerclage, ~ 15 % with cerclage); interpregnancy interval ≥ 18 mo; lifestyle optimization.
Trigger could not be auto-evaluated — needs clinician judgement.
informationalmildhistory_indicated_cerclage_at_13_14wk
Patient with ≥ 1 prior 2nd-trimester loss attributable to painless cervical dilation (some criteria require ≥ 2 prior) + no other identifiable cause + current singleton pregnancy → schedule elective McDonald or Shirodkar cerclage at 12-14 wk gestation (ACOG PB 234). Pre-procedural workup (CBC + CMP + coag + UA + cervicovaginal swabs) + treat any positive infection BEFORE placement. Remove at 36-37 wk antepartum OR emergently for PTL refractory tocolysis / chorio / PPROM / bleeding.
Trigger could not be auto-evaluated — needs clinician judgement.
informationalmildcervical_pessary_alternative
Cerclage declined by patient OR contraindicated + short cervix < 25 mm singleton at 18-22 wk → cervical pessary (Arabin or Bioteque) as alternative; Goya 2012 PMID 22475493 (PECEP positive trial) but NOT replicated in OPPTIMUM 2016 or ProTwin 2013 (twins negative). Mixed evidence base; not first-line per ACOG PB 234. Informed consent re uncertain benefit.
Trigger could not be auto-evaluated — needs clinician judgement.

Workflow calculators

This dossier does not reference any calculators.

Recommended regimen

Cervical insufficiency management — cerclage (history-, US-, exam-indicated) + vaginal progesterone (asymptomatic short cervix no prior PTB) + pessary alternative (ACOG PB 234 + PB 130 + Berghella 2011 + Owen 2009 + Hassan 2011 + Romero 2017 + Roman 2020 + CIPRACT 2003)

axis: cervical_insufficiency_managementstep history_indicated_cerclage_elective_12_to_14wk - History-indicated cerclage at 12-14 wk — elective McDonald or Shirodkar (ACOG PB 234)

Selected step "History-indicated cerclage at 12-14 wk — elective McDonald or Shirodkar (ACOG PB 234)" — ≥ 1 prior 2nd-trimester loss attributable to painless cervical dilation (some criteria ≥ 2) + no other identifiable cause + current singleton pregnancy + 12-14 wk gestation

McDonald cerclage (transvaginal purse-string)
first line
surgical_cerclage
McDonald purse-string suture at cervico-vaginal junction; placed at 12-14 wk under regional or general anesthesia; outpatient procedure with overnight observation typical • transvaginal_surgical • single placement; remove at 36-37 wk antepartum
triggers: history_indicated_cerclage_substrate
ACOG PB 234 + Cochrane 2017 (Alfirevic PMID 28586127) — elective cerclage reduces recurrent 2nd-trimester loss in history-indicated patients; McDonald is most commonly used; Shirodkar (submucosal) is technically more demanding but comparable outcomes
Shirodkar cerclage (transvaginal submucosal)
second line
surgical_cerclage
Shirodkar suture placed submucosally at cervico-vaginal junction; technically more demanding; outcomes comparable to McDonald per modern RCT data • transvaginal_surgical • single placement; remove at 36-37 wk
triggers: history_indicated_cerclage_substrate_with_anatomic_consideration
Comparable outcomes to McDonald per Cochrane 2017; reserved for selected anatomic cases

outpatient playbook — drug actions (4)

1. vaginal progesterone antepartum (short cervix no prior PTB)
rxcui 8727
200 mg PV nightly from CL < 25 mm diagnosis through 36+6 wk • PV • nightly
trigger: Asymptomatic singleton CL < 25 mm (preferred < 20 mm) at 18-24 wk WITHOUT prior PTB
Hassan 2011 PMID 21472815 + Romero 2017 PMID 29630885 — reduces preterm birth before 33 wk; NOT effective in multifetal
2. aspirin prophylaxis if high-risk for pre-eclampsia
rxcui 1191
81-150 mg PO daily from 12 wk through 36 wk • PO • daily
trigger: High risk per USPSTF 2021 (prior PE, chronic HTN, DM, CKD, autoimmune)
ASPRE 2017 + USPSTF 2021 — reduces preterm PE specifically; co-occurs in some high-risk CI patients
3. acetaminophen post-procedural
rxcui 161
650-1000 mg PO q6h PRN • PO • q6h PRN
trigger: Post-cerclage pain or fever short course
Pain + fever control after elective cerclage outpatient procedure; avoid NSAIDs in 3rd trimester (PDA closure)
4. iron repletion if antepartum anemia
Ferrous sulfate 325 mg PO TID; IV iron if severe • PO/IV • TID PO or per infusion protocol
trigger: Hgb < 11 g/dL
Restore iron stores; improve recovery + reduce fatigue

Auto-drafted A&P note

outpatient

Subjective

- Possible entry pathways: ≥ 1 prior 2nd-trimester pregnancy loss attributable to painless cervical dilation with no other identifiable cause (ACOG PB 234 history-indicated cerclage substrate); TVUS cervical length < 25 mm before 24 wk in singleton with prior spontaneous preterm birth (US-indicated cerclage substrate per Berghella 2011 PMID 21446209; Owen 2009 PMID 19788970); TVUS cervical length < 25 mm at 18-24 wk in asymptomatic singleton WITHOUT prior preterm birth — vaginal progesterone indication per Hassan 2011 PMID 21472815; Romero 2017 PMID 29630885.

Objective

- No vitals, labs, or imaging entered for this encounter.

Assessment

**Cervical Insufficiency (Painless 2nd-Trimester Cervical Dilation)** (ob.cervical-insufficiency.v1).
Phenotype framing: Preterm labor (regular contractions + cervical change → ob.preterm-labor.v1), placental abruption (painful bleeding + tachysystole → ob.placental-abruption.v1), chorioamnionitis (fever + Higgins 2016 → ob.chorioamnionitis.v1), PPROM (ROM at < 37 wk → ob.preterm-labor.v1 PPROM branch), congenital uterine anomaly as primary cause of loss (MFM / REI referral for surgical correction), abnormal placentation (placenta previa / accreta — separate management).
Scope: Cervical insufficiency = painless cervical dilation in 2nd trimester (typically 16-24 wk) without contractions, with risk of mid-trimester loss or extreme-preterm birth. Pathophysiology is mechanical (cervical structural weakness) rather than the contraction-driven mechanism of PTL. Partition by indication tier: history-indicated (prior 2nd-trimester loss) vs ultrasound-indicated (prior PTB + current CL < 25 mm) vs physical-exam-indicated (dilated cervix + bulging membranes) vs asymptomatic-short-cervix-no-prior-PTB (vaginal progesterone). Distinguishes from preterm labor (regular contractions + cervical change at 20-37 wk; routes to ob.preterm-labor.v1), placental abruption (painful bleeding; ob.placental-abruption.v1), chorioamnionitis (fever + Higgins criteria; ob.chorioamnionitis.v1).

No severity triggers fired against current inputs.

Plan

Regimen axis: **Cervical insufficiency management — cerclage (history-, US-, exam-indicated) + vaginal progesterone (asymptomatic short cervix no prior PTB) + pessary alternative (ACOG PB 234 + PB 130 + Berghella 2011 + Owen 2009 + Hassan 2011 + Romero 2017 + Roman 2020 + CIPRACT 2003)** — step "History-indicated cerclage at 12-14 wk — elective McDonald or Shirodkar (ACOG PB 234)".
1. McDonald cerclage (transvaginal purse-string) McDonald purse-string suture at cervico-vaginal junction; placed at 12-14 wk under regional or general anesthesia; outpatient procedure with overnight observation typical transvaginal_surgical single placement; remove at 36-37 wk antepartum (surgical_cerclage, first line) — ACOG PB 234 + Cochrane 2017 (Alfirevic PMID 28586127) — elective cerclage reduces recurrent 2nd-trimester loss in history-indicated patients; McDonald is most commonly used; Shirodkar (submucosal) is technically more demanding but comparable outcomes
2. Shirodkar cerclage (transvaginal submucosal) Shirodkar suture placed submucosally at cervico-vaginal junction; technically more demanding; outcomes comparable to McDonald per modern RCT data transvaginal_surgical single placement; remove at 36-37 wk (surgical_cerclage, second line) — Comparable outcomes to McDonald per Cochrane 2017; reserved for selected anatomic cases

Setting playbook (outpatient) — Antepartum MFM clinic — pre-conception counseling for prior CI; surveillance for high-risk pregnancies (prior PTB, prior 2nd-trimester loss, multifetal); serial TVUS CL q1-2 wk from 16 wk; vaginal progesterone for asymptomatic short cervix without prior PTB; elective cerclage scheduling at 12-14 wk (history-indicated); 6-week postpartum visit + recurrence counseling + preconception MFM consult for next pregnancy
3. vaginal progesterone antepartum (short cervix no prior PTB) 200 mg PV nightly from CL < 25 mm diagnosis through 36+6 wk PV nightly — Asymptomatic singleton CL < 25 mm (preferred < 20 mm) at 18-24 wk WITHOUT prior PTB (Hassan 2011 PMID 21472815 + Romero 2017 PMID 29630885 — reduces preterm birth before 33 wk; NOT effective in multifetal)
4. aspirin prophylaxis if high-risk for pre-eclampsia 81-150 mg PO daily from 12 wk through 36 wk PO daily — High risk per USPSTF 2021 (prior PE, chronic HTN, DM, CKD, autoimmune) (ASPRE 2017 + USPSTF 2021 — reduces preterm PE specifically; co-occurs in some high-risk CI patients)
5. acetaminophen post-procedural 650-1000 mg PO q6h PRN PO q6h PRN — Post-cerclage pain or fever short course (Pain + fever control after elective cerclage outpatient procedure; avoid NSAIDs in 3rd trimester (PDA closure))
6. iron repletion if antepartum anemia Ferrous sulfate 325 mg PO TID; IV iron if severe PO/IV TID PO or per infusion protocol — Hgb < 11 g/dL (Restore iron stores; improve recovery + reduce fatigue)

Non-pharmacologic actions:
- Pre-conception counseling for prior CI patients: cerclage planning for next pregnancy; uterine-anomaly workup; connective-tissue review
- Elective cerclage scheduling at 12-14 wk (history-indicated) — outpatient procedure with overnight observation; pre-procedural infection screen + treat
- Serial TVUS cervical length surveillance q1-2 wk from 16 wk in high-risk pregnancies
- Vaginal progesterone counseling for asymptomatic short cervix without prior PTB
- Bed rest is NOT routinely recommended — increases VTE risk + does not prevent PTB
- Cervical pessary alternative discussion in select cases where cerclage declined or contraindicated; informed consent re uncertain benefit (CIPRACT + ProTwin + OPPTIMUM mixed)
- Mental health support during prolonged surveillance especially after prior CI-attributable loss; partner / family inclusion
- Recurrence-risk counseling + preconception MFM consult for next pregnancy planning
- Antepartum lifestyle counseling — smoking cessation, substance use, glycemic control if DM, BP control if HTN
- Vaccinations review per ACIP (Tdap, flu, COVID)

AVOID / contraindication checks:
- Cerclage CONTRAINDICATED in active chorioamnionitis foreign body in infected field mandates removal (ACOG PB 234)
- Cerclage CONTRAINDICATED in active PTL with regular contractions not CI pathway (ACOG PB 234)
- Cerclage CONTRAINDICATED in active vaginal bleeding and suspected abruption (ACOG PB 234)
- Cerclage CONTRAINDICATED in IUFD and lethal fetal anomaly (ACOG PB 234)
- Routine cerclage NOT recommended in multifetal gestation per Berghella 2017 IPD meta analysis rescue cerclage only at advanced dilation per Roman 2020
- Vaginal progesterone NOT effective for multifetal gestation per Romero 2018 IPD meta analysis (Romero AJOG 2018 PMID 29630885)
- Indomethacin CONTRAINDICATED at or after 32 wk ductus closure and oligohydramnios (ACOG PB 234)
- No digital cervical exam if PPROM suspected ascending infection risk (ACOG PB 188)
- Cerclage removal MANDATORY at chorioamnionitis confirmation foreign body in infected field (ACOG PB 234)
- Cerclage removal EMERGENT at PTL refractory tocolysis to avoid cervical laceration (ACOG PB 234)
- Cerclage removal USUALLY within 24 to 48h of PPROM diagnosis given ascending infection risk (ACOG PB 234)
- Elective cerclage removal at 36 to 37 wk antepartum to allow vaginal delivery (ACOG PB 234)
- Transabdominal cerclage MANDATES cesarean delivery left in situ for future pregnancies
- Pre procedural infection screen and treat before elective cerclage placement GBS chlamydia gonorrhea BV UTI
- Berghella 2017 IPD meta analysis cerclage NOT beneficial in singletons with short cervix WITHOUT prior PTB use vaginal progesterone instead

Monitoring

Regimen monitoring:
- Post-cerclage observation 24-48 h (history- or US-indicated) OR 48-72 h (rescue cerclage with indomethacin tocolysis)
- Maternal vitals q4 h × 24 h post-procedure; maternal temperature q4 h × 48 h (chorio surveillance)
- Fetal HR confirmation post-procedure + intermittent fetal monitoring per MFM protocol
- Serial TVUS cervical length q1-2 wk during expectant management
- Antepartum surveillance daily fetal kick counts after 24 wk; NST / BPP per MFM protocol from 28-32 wk in high-risk
- Weekly amniotic fluid index during expectant management
- Symptom monitoring: contractions (PTL emergence), fever (chorio), bleeding (abruption), rupture of membranes (PPROM)
- Indomethacin tocolysis monitoring: weekly AFI if > 48 h use; CONTRAINDICATED at or after 32 wk
- 36-37 wk elective cerclage removal antepartum to allow vaginal delivery

Setting (outpatient) monitoring:
- 6-week postpartum visit; additional 1-2 wk visit if cesarean wound concern
- Antepartum TVUS CL q1-2 wk in high-risk pregnancies from 16-24 wk
- NST + BPP weekly from 32-34 wk if high-risk
- Maternal mental health re-screen at 6 wk + 3 mo + 6 mo (peripartum PTSD risk elevated after CI-attributable loss)
- Preconception MFM consultation when contemplating next pregnancy
- Lifelong CV-risk follow-up not specifically driven by CI (vs PE / GHTN which doubles CV risk)

Follow-up plan: 6-week postpartum visit + CI-specific anticipatory guidance: recurrence ~ 15-30 % in subsequent pregnancy; preconception MFM consult for next pregnancy planning (cerclage indication review; uterine-anomaly workup with 3D US / saline-infusion sonohysterogram if recurrent loss despite cerclage; connective-tissue / autoimmune review). Mental health screen (EPDS for postpartum depression; PCL-5 for peripartum PTSD especially after mid-trimester loss or extreme preterm). Contraception counseling + interpregnancy interval ≥ 18 mo. Immunization audit (Tdap, flu, COVID per ACIP). Newborn outpatient peds follow-up if delivery occurred preterm.
- Close-out criterion: Postpartum visit complete; preconception MFM counseling delivered; mental health + immunization + newborn follow-up arranged

Monitoring phase: Post-cerclage observation: maternal vitals q4 h × 24 h (more frequent if rescue / indomethacin tocolysis); maternal temperature q4 h (chorio surveillance); fetal HR confirmation post-procedure. Serial TVUS cervical length q1-2 wk during expectant management. Antepartum surveillance: daily fetal kick counts after 24 wk; NST / BPP per MFM protocol from 28-32 wk in high-risk; weekly amniotic fluid index. Symptom monitoring: contractions (PTL emergence), fever (chorio), bleeding (abruption), rupture of membranes (PPROM). At 36-37 wk: elective cerclage removal antepartum to allow vaginal delivery.

Disposition

Current setting: outpatient — Antepartum MFM clinic — pre-conception counseling for prior CI; surveillance for high-risk pregnancies (prior PTB, prior 2nd-trimester loss, multifetal); serial TVUS CL q1-2 wk from 16 wk; vaginal progesterone for asymptomatic short cervix without prior PTB; elective cerclage scheduling at 12-14 wk (history-indicated); 6-week postpartum visit + recurrence counseling + preconception MFM consult for next pregnancy

Disposition criteria:
- Asymptomatic short cervix on vaginal progesterone → continue outpatient surveillance q1-2 wk TVUS
- History-indicated cerclage placed at 12-14 wk → outpatient with 1-2 wk follow-up post-procedure
- 6-week postpartum complete + mental health stable + contraception in place + preconception MFM arranged → discharge to routine prenatal care + MFM for next pregnancy when contemplated

Escalation triggers (move to higher acuity):
- New contractions / cramping / decreased fetal movement → return to L&D / ED
- Painless cervical dilation on routine speculum exam at 16-24 wk → urgent OB consult for rescue cerclage decision
- TVUS CL < 25 mm with prior PTB → cerclage decision per Berghella 2011
- New mental health crisis (PHQ-9 ≥ 15 or PCL-5 with suicidal ideation) → urgent mental health referral

Earlier-Return Triggers

Return-precaution thresholds (watch for):
- [SEVERE] Prior spontaneous preterm birth + current singleton pregnancy + TVUS cervical length < 25 mm before 24 wk → cerclage placement between 16+0 and 23+6 wk (Berghella Obstet Gynecol 2011 PMID 21446209; Owen Am J Obstet Gynecol 2009 PMID 19788970). Reduces preterm birth before 35 wk (RR 0.70), previable birth, and perinatal mortality + composite morbidity. Pre-procedural infection screen + treat. Post-procedural observation 24-48 h. Serial TVUS surveillance q1-2 wk.
- [SEVERE] Cervical dilation ≥ 1-2 cm + visible / bulging amniotic membranes 16+0 to 23+6 wk WITHOUT contractions, infection, or bleeding → emergent rescue cerclage with pre-procedural antibiotics + indomethacin tocolysis (if < 32 wk) per CIPRACT Althuisius 2003 PMID 14586323 + ACOG PB 234. Efficacy controversial; observational + case-series data suggest GA prolongation 4-6 wk. Informed consent essential.
- [SEVERE] Cerclage in situ + complication emergence: (a) regular contractions / PTL refractory to tocolysis → emergent cerclage REMOVAL to avoid cervical laceration; (b) maternal fever + Higgins 2016 criteria → CHORIO → MANDATORY cerclage removal + ampicillin + gentamicin empirics + expedite delivery; (c) PPROM at < 37 wk → case-by-case removal usually within 24-48 h given ascending infection risk; (d) significant vaginal bleeding → case-by-case observation vs removal depending on abruption ddx. Routes to ob.preterm-labor.v1 or ob.chorioamnionitis.v1 or ob.placental-abruption.v1 with cerclage carryover state.

Citations

- ACOG Practice Bulletin 234 (2014, reaffirmed 2021) Cerclage for the Management of Cervical Insufficiency + ACOG PB 130 (2012, reaffirmed) Prediction and Prevention of Preterm Birth + SMFM Consult Series #20 (2020) Cervical Insufficiency + Berghella Obstet Gynecol 2011 (PMID 21446209) IPD meta-analysis cerclage for short cervix singleton + Owen Am J Obstet Gynecol 2009 (PMID 19788970) NICHD MFMU RCT cerclage in prior PTB + short cervix + Hassan Ultrasound Obstet Gynecol 2011 (PMID 21472815) vaginal progesterone short cervix + Romero AJOG 2018 (PMID 29630885) vaginal progesterone IPD meta-analysis + Roman Am J Obstet Gynecol 2020 (PMID 32592693) twin rescue cerclage RCT + CIPRACT Althuisius 2003 (PMID 14586323) cerclage RCT + Goya PECEP 2012 (PMID 22475493) cervical pessary RCT + Alfirevic Cochrane 2017 (PMID 28586127) cerclage Cochrane meta-analysis [PMID:21446209](https://pubmed.ncbi.nlm.nih.gov/21446209/)
- Cited evidence (PMID 19788970) [PMID:19788970](https://pubmed.ncbi.nlm.nih.gov/19788970/)
- Cited evidence (PMID 21472815) [PMID:21472815](https://pubmed.ncbi.nlm.nih.gov/21472815/)
- Cited evidence (PMID 29630885) [PMID:29630885](https://pubmed.ncbi.nlm.nih.gov/29630885/)
- Cited evidence (PMID 32592693) [PMID:32592693](https://pubmed.ncbi.nlm.nih.gov/32592693/)

Last reconciled with current guidelines: 2026-05-15.

References

ACOG Practice Bulletin 234 (2014, reaffirmed 2021) Cerclage for the Management of Cervical Insufficiency + ACOG PB 130 (2012, reaffirmed) Prediction and Prevention of Preterm Birth + SMFM Consult Series #20 (2020) Cervical Insufficiency + Berghella Obstet Gynecol 2011 (PMID 21446209) IPD meta-analysis cerclage for short cervix singleton + Owen Am J Obstet Gynecol 2009 (PMID 19788970) NICHD MFMU RCT cerclage in prior PTB + short cervix + Hassan Ultrasound Obstet Gynecol 2011 (PMID 21472815) vaginal progesterone short cervix + Romero AJOG 2018 (PMID 29630885) vaginal progesterone IPD meta-analysis + Roman Am J Obstet Gynecol 2020 (PMID 32592693) twin rescue cerclage RCT + CIPRACT Althuisius 2003 (PMID 14586323) cerclage RCT + Goya PECEP 2012 (PMID 22475493) cervical pessary RCT + Alfirevic Cochrane 2017 (PMID 28586127) cerclage Cochrane meta-analysis — PMID:21446209
Cited evidence (PMID 19788970) — PMID:19788970
Cited evidence (PMID 21472815) — PMID:21472815
Cited evidence (PMID 29630885) — PMID:29630885
Cited evidence (PMID 32592693) — PMID:32592693